Compass Wealth Management LLC Sells 53,885 Shares of Option Care Health, Inc. $OPCH

Compass Wealth Management LLC lessened its position in Option Care Health, Inc. (NASDAQ:OPCH) by 23.3% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 177,062 shares of the company’s stock after selling 53,885 shares during the period. Compass Wealth Management LLC owned approximately 0.12% of Option Care Health worth $3,982,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Group Inc. acquired a new position in shares of Option Care Health during the first quarter worth approximately $70,287,000. Van Berkom & Associates Inc. bought a new position in shares of Option Care Health in the 1st quarter worth $42,739,000. Bank of New York Mellon Corp bought a new position in shares of Option Care Health in the 2nd quarter worth $19,600,000. Southpoint Capital Advisors LP lifted its holdings in shares of Option Care Health by 20.0% in the 1st quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after purchasing an additional 600,000 shares in the last quarter. Finally, Squarepoint Ops LLC grew its position in Option Care Health by 234.1% in the 2nd quarter. Squarepoint Ops LLC now owns 434,408 shares of the company’s stock valued at $9,110,000 after purchasing an additional 304,376 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

OPCH stock opened at $31.29 on Friday. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. The stock’s 50 day moving average is $25.57 and its 200-day moving average is $23.84. The firm has a market capitalization of $4.69 billion, a PE ratio of 23.53, a P/E/G ratio of 1.90 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. The company had revenue of $1.44 billion for the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter in the previous year, the firm earned $0.41 earnings per share. Option Care Health’s quarterly revenue was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Sell-side analysts expect that Option Care Health, Inc. will post 1.70 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have commented on OPCH shares. William Blair lowered shares of Option Care Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, October 6th. Citizens Jmp downgraded shares of Option Care Health from a “market outperform” rating to a “hold” rating in a report on Wednesday, October 7th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $24.00 price objective (down from $26.00) on shares of Option Care Health in a research note on Thursday, July 30th. UBS Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $39.00 to $32.05 in a report on Friday, October 9th. Finally, Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and boosted their target price for the stock from $28.00 to $32.05 in a research report on Tuesday, October 6th. Two research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $29.48.

Option Care Health Profile

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.